Johan M.
- Country
- Sweden
- Department
- Barncanceravdelningen
Research Overview
- Evaluation of Triptorelin for Ovarian Reserve Preservation in Young Females Undergoing Chemotherapy for Breast Cancer, Leukemia, Lymphomas, and Sarcomas
- ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) with Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Data & Insights
Has run more than one trial at 4 of 85 partner sites.
Specializations
Oncology and Hematology
Specializes in comprehensive treatment approaches for breast cancer, acute leukemia, and various types of lymphomas, including both Hodgkin and non-Hodgkin variants.
- Breast Cancer Treatment
- Hematologic Malignancies
- Pediatric and Young Adult Oncology
Particular focus on treatment protocols for patients aged 0-45 years with acute lymphoblastic leukemia.
Fertility Preservation
Investigates fertility preservation strategies in cancer patients, with emphasis on ovarian reserve protection during chemotherapy treatment.
- Gonadotoxicity Prevention
- Hormone Preservation Strategies
- Anti-Müllerian Hormone Monitoring
Evaluates the effectiveness of GnRH agonists in preserving fertility during cancer treatment.
Treatment Innovation
Develops advanced therapeutic approaches for sarcomas, including osteosarcoma, soft tissue sarcoma, and Ewing sarcoma.
- Novel Immunotherapy Applications
- Survival Outcome Improvement
- Quality of Survival Enhancement
Focuses on integrating targeted therapies with conventional treatment modalities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
